Weekly Insider Report: Biotech and Medical Stocks

The BHI Weekly Insider Report is posted on BHI once a week, usually on Sunday or Monday. BHI does not take any responsibility for any financial loss or damage caused by or related to the following reports. BHI does not guarantee the accuracy of the reports. The following information should be used for entertainment purposes only.


This week's report:

BIOTECH
bought Genitope (GTOP): Feb 5, $3.80
bought Molecular Insight (MIPI): Feb 2, $13.88
bought Inhibitex (INHX): Feb 2, $1.59

sold Biogen Idec (BIIB): Feb 6-7, $48.94-$49.32
sold Human Genome Sci (HGSI): Feb 1-2, $11.75-$12
sold Parexel Intl (PRXL): Feb 2, $33.60
sold Gilead Sci (GILD): Feb 1-6, $69.90-$71.10
sold Illumina (ILMN): Feb 1-6, $35.23-$41.96
sold Cambrex Corp (CBM): Feb 2-9, $20.72-$23.30
sold ViroPharma (VPHM): Feb 7, $18-$18.04
sold Amylin (AMLN): Feb 5-7, $40.52
sold Vertex Pharm (VRTX): Feb 5-7, $32.64-$32.89
sold Exelixis (EXEL): Feb 1, $9.90-$10.11
sold Acorda Ther (ACOR): Feb 17.45-$17.78
sold Vanda Pharm (VNDA): Feb 1, $29.42-$29.80
sold Charles River Labs (CRL): Feb 1, $45


DRUGS
bought Johnson & Johnson (JNJ): Feb 2, $66.78

sold Meridian Biosci (VIVO): Feb 1-8, $29.12-$29.77
sold Merck (MRK): Feb 6, $41.41-44.53
sold Abbott Labs (ABT): Feb 1-2, $52.61-$52.87
sold Pfizer (PFE): Feb 7-8, $26.45-$26.54
sold Zimmer Holdings (ZMH): Feb 2-8, $83.01-$85.28
sold United Ther (UTHR): Feb 1, $52.58-$53.54
sold Noven (NOVN): Feb 7, $27.80
sold Progenix Pharma (PGNX): Feb 2, $30.05-$30.15



Medical Supplies
bought QMed (QMED): Feb 1, $4.32

sold Arrow Intl (ARRO): Feb 2-8, $33.66-$33.88
sold McKesson Corp (MCK): Feb 6-8, $55.53-$55.77
sold St. Jude Medical (STJ): Feb 5, $42.50-$42.57
sold Rochester Medical (ROCM): Feb 5-7, $16.12-$18.90



Previous BHI Weekly Insider Reports
____________________